13THERAPEUTICS
13Therapeutics, Inc is a spin out from the Oregon Health and Science University (OHSU) and has exclusively licensed peptides on a world-wide basis. U.S. patents claiming the composition of the lead peptide and its use in all inflammatory conditions involving Toll-Like Receptor (TLR) signaling have been issued, and several additional patents have been issued. The company performs all in vitro testing in-house and subcontracts with OHSU and other academic instututions for animal model testing. The company is privately funded and has received NIH peer reviewed grants, including multiple Phase II and Phase II SBIR grants.
13THERAPEUTICS
Industry:
Health Care
Founded:
2008-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.13therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(503)525-4887
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Mobile Non Scaleable Content Microsoft Exchange Online Amazon Organization Schema Office 365 Mail Google Maps
Current Employees Featured
Founder
Investors List
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) investment in Grant - 13Therapeutics
Official Site Inspections
http://www.13therapeutics.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
